Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.
Biochimica Et Biophysica Acta
Ruvolo, Peter P PP; Ruvolo, Vivian R VR; Benton, Christopher B CB; AlRawi, Ahmed A; Burks, Jared K JK; Schober, Wendy W; Rolke, James J; Tidmarsh, George G; Hail, Numsen N; Davis, R Eric RE; Andreeff, Michael M